Sharing standardized image-derived data in computational pathology using DICOM
Authors: Daniela P. Schacherer, Christopher P. Bridge, David Clunie, Igor Octaviano, André Homeyer, Markus D. Herrmann, Olivier Gevaert, Tabita Ghete, +8 more
Organizations: Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany · Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, USA · Harvard Medical School, Boston, USA · PixelMed Publishing, Bangor, USA · Radical Imaging LLC, USA · Massachusetts General Hospital, Boston, USA · Stanford University, Stanford, USA · University Hospital Erlangen, Erlangen, Germany · Stony Brook University, Stony Brook, USA · National Institute of Allergy and Infectious Diseases, Bethesda, USA · Google Research, Mountain View, USA · Brigham and Women's Hospital, Boston, USA
Development and evaluation of computational pathology methods require access to large and diverse datasets. Over the past decade, various initiatives invested significantly into collecting, centralizing, and sharing pathology imaging data. In contrast, sharing of image-derived data such as region-of-interest delineations or segmentation masks is less well developed. In this work, we describe our approach to encoding and sharing image-derived pathology data in a standardized manner within the National Cancer Institute (NCI) Imaging Data Commons (IDC), a platform that hosts and provides public access to de-identified radiology and pathology data. The IDC relies on the Digital Imaging and Communications in Medicine (DICOM) standard for data harmonization, yet the adoption of DICOM for pathology image-derived content has remained largely unexplored until now. Here, we present five representative datasets harmonized by conversion from their original representations into DICOM and shared publicly in the IDC. We demonstrate the benefits of this harmonization, describe contributions to critical open-source tooling, and discuss technical considerations relevant to broader adoption of DICOM for pathology image-derived data.
Medical imaging AI development is fundamentally dependent on annotated datasets, yet no existing standard provides machine-enforceable validation across dataset structure, annotation provenance, quality documentation, and ML readiness within a single framework. DICOM standardizes image acquisition, storage, and communication at the individual study level. BIDS organizes neuroimaging research datasets with consistent naming conventions. Neither addresses the curation layer, viz., who annotated what, when, with what tool, and to what quality standard. This paper presents VIDS (Verified Imaging Dataset Standard), an open specification that defines folder layout, file naming, annotation provenance schemas, quality documentation, and 21 machine-enforceable validation rules across two compliance profiles. VIDS uses NIfTI as a canonical working format while preserving full DICOM metadata in sidecars for traceability, and supports export to any downstream ML framework (nnU-Net, MONAI, COCO, flat NIfTI) without loss of provenance. Twenty-two compliance dimensions are defined and four major public datasets -- LIDC-IDRI, BraTS, CheXpert, and the Medical Segmentation Decathlon -- are benchmarked against these dimensions. Even widely used datasets satisfy only 20--39% of these dimensions, with provenance and quality documentation as the largest systematic gaps. LIDC-Hybrid-100 is released as a 100-subject VIDS-compliant reference CT dataset with consensus segmentation masks from four radiologist annotations (mean pairwise Dice 0.7765), validating 21/21 on the Full compliance profile. VIDS is fully open source: the specification is CC BY 4.0, all tools are Apache 2.0, the reference validator is available on PyPI (pip install vids-validator), and LIDC-Hybrid-100 is published on Zenodo (https://doi.org/10.5281/zenodo.19582717).
Batch effects arising from technical variations in histopathology staining protocols, scanners, and acquisition pipelines pose a persistent challenge for computational pathology, hindering cross-batch generalization and limiting reliable deployment of models across clinical sites. In this work, we introduce Latent Manifold Compaction (LMC), an unsupervised representation learning framework that performs image harmonization by learning batch-invariant embeddings from a single source dataset through explicit compaction of stain-induced latent manifolds. This allows LMC to generalize to target domain data unseen during training. Evaluated on three challenging public and in-house benchmarks, LMC substantially reduces batch-induced separations across multiple datasets and consistently outperforms state-of-the-art normalization methods in downstream cross-batch classification and detection tasks, enabling superior generalization.
Xiaolong Zhang, Jianwei Zhang, Selim Sevim +3
Knight Cancer Institute, Oregon Health and Science University, Oregon, USA · Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University, Oregon, USA
Computational biomarkers (CBs) are histopathology-derived patterns extracted from hematoxylin-eosin (H&E) whole-slide images (WSIs) using artificial intelligence (AI) to predict therapeutic response or prognosis. Recently, slide-level multiple-instance learning (MIL) with pathology foundation models (PFMs) has become the standard baseline for CB development. While these methods have improved predictive performance, computational pathology lacks standardized intermediate data formats, provenance tracking, checkpointing conventions, and reproducible evaluation metrics required for clinical-grade deployment. We introduce GOLDMARK (https://artificialintelligencepathology.org), a standardized benchmarking framework built on a curated TCGA cohort with clinically actionable OncoKB level 1-3 biomarker labels. GOLDMARK releases structured intermediate representations, including tile coordinate maps, per-slide feature embeddings from canonical PFMs, quality-control metadata, predefined patient-level splits, trained slide-level models, and evaluation outputs. Models are trained on TCGA and evaluated on an independent MSKCC cohort with reciprocal testing. Across 33 tumor-biomarker tasks, mean AUROC was 0.689 (TCGA) and 0.630 (MSKCC). Restricting to the eight highest-performing tasks yielded mean AUROCs of 0.831 and 0.801, respectively. These tasks correspond to established morphologic-genomic associations (e.g., LGG IDH1, COAD MSI/BRAF, THCA BRAF/NRAS, BLCA FGFR3, UCEC PTEN) and showed the most stable cross-site performance. Differences between canonical encoders were modest relative to task-specific variability. GOLDMARK establishes a shared experimental substrate for computational pathology, enabling reproducible benchmarking and direct comparison of methods across datasets and models.
Chad Vanderbilt, Gabriele Campanella, Siddharth Singi +10
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA · Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA